Medical Devices & Surgical Technology Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices & Surgical Technology Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bioartificial Liver
Bioartificial liver effectively treats fulminant hepatic failure
April 11th, 2006
A bioartificial liver effectively treats fulminant hepatic failure. According to recently published research from the People's Republic of China, "We developed a bioartificial liver (VIAL) based on a direct hemoperfusion typed nonwoven fabric bioreactor containing porcine hepatocytes. "In this study, the efficacy of our VIAL was evaluated with a pig fulminant hepatic failure (FHF) model. FHF was induced with intravenous administration of D-galactosamine (1.3 g/kg) in each pig." "Twelve hours post D-galactosamine injection, fifteen pigs were divided into: a VIAL group (n=5), in which pigs received the VIAL treatment with 1.0 to...
Source: Medical Devices & Surgical Technology Week (2006-04-11)
|
